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Background
Cardiac NO-activated pathways are discussed to involve
cross-talk between cGMP and cAMP signalling [1,2].
Here we have investigated the signalling pathways relat-
ing to NO-donor S-nitroso-N-acetylpenicillamine
(SNAP) modulation of L-type Ca
2+ current (ICa,L)i n
human right atrial cardiomyocytes.
Material and methods
Experiments were performed on human biopsy tissue
from 62 patients in sinus rhythm. ICa,L was measured
with whole-cell voltage-clamp technique.
Results
Application of SNAP (100µM) increased basal ICa,L from
5.93±0.23 pA/pF to 9.10±0.45pA/pF (p<0.001, n/N=117/
62). The effect was abolished by inhibition of soluble gua-
nylate cyclase (sGC) with ODQ (30µM), suggesting invol-
vement of cGMP. Stimulator of sGC (BAY 41-2272,
10nM–10µM) also increased ICa,L and this effect was
potentiated in the presence of SNAP. Direct activation of
protein kinase G (PKG) with 8-Br-cGMP (100 µM, intra-
cellular application) increased basal ICa,L. However, not
only cGMP but also cAMP was involved, because, the
effect of SNAP on ICa,L was prevented with the protein
kinase A blocker (Rp-8-Br-cAMP 1 mM, intracellular).
Thus, cGMP may activate ICa,L via direct activation of
PKG and indirect activation of PKA at the same time. It is
known, that cAMP-mediated activation of PKA is regu-
lated by cGMP via modulation of phosphodiesterases
(PDEs). The selective PDE2 inhibitor EHNA (10µM) did
not affect basal or SNAP-stimulated ICa,L, therefore PDE2
does not regulate basal cAMP level. In contrast, PDE3
inhibition with cilostamide (1µM) increased basal ICa,L,
suggesting that PDE3 is involved in basal cAMP level reg-
ulation. Interestingly, the cilostamide-induced increase in
ICa,L is blunted upon addition of SNAP, most probably via
activation of PDE2 by SNAP-mediated cGMP increase
(Figure 1). Similarly, SNAP blunted enhancement of ICa,L
by PKA activation with isoprenalin (1µM; 18.07 ± 1.12
pA/pF vs 23.06 ± 1.36 pA/pF, p<0.001, n/N=21-39/18),
however, this effect was prevented by PDE2 inhibition
with EHNA.
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Figure 1 Effect of SNAP (100µM), PDE2 inhibitor (EHNA, 10µM) and
PDE3 inhibitor (Cilostamide, 1µM) on ICa,L. SNAP effect in the
presence of cilostamide.
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We conclude that in human atrial cardiomyocytes NO-
donors stimulate production of cGMP with further
cross-talk to cAMP via PDE2 and PDE3.
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